We are live on ! Find out more
BSTG

Biostage, Inc. Common Stock
BSTG

Delisted

BSTG was delisted on the 5th of October, 2017.

28 hedge funds and large institutions have $5.38M invested in Biostage, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more capital invested

Capital invested by funds: $2.13M → $5.38M (+$3.25M)

7% less funds holding

Funds holding: 3028 (-2)

22% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 9

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
28
Holders Change
-2
Holders Change %
-6.67%
% of All Funds
0.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
7
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change

BSTG Hedge Fund Activity: Q4 2015 in Review

28 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Biostage, Inc. Common Stock (BSTG) for Q4 2015, worth a combined $5.38M — up 152% from $2.13M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of BSTG and 6 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $332K. The largest seller was State of New Jersey Common Pension Fund D, cutting an estimated $474K.

  • 28 institutional investors held Biostage, Inc. Common Stock (BSTG) as of Q4 2015, down from 30 in Q3 2015.
  • Funds reported $5.38M of Biostage, Inc. Common Stock stock for Q4 2015, up 152% quarter-over-quarter.
  • 6 funds opened new Biostage, Inc. Common Stock positions in Q4 2015 and 8 closed out, a net change of -2 holders.
  • The largest Biostage, Inc. Common Stock buyer in Q4 2015 was Renaissance Technologies, an estimated $332K added.
  • The largest Biostage, Inc. Common Stock seller in Q4 2015 was State of New Jersey Common Pension Fund D, an estimated $474K sold.

Based on aggregated 13F filings for Q4 2015.